ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,079,000 | -14.7% | 344,781 | -49.0% | 0.01% | -25.0% |
| Q3 2019 | $2,436,000 | +70.8% | 676,688 | +27.2% | 0.01% | +60.0% |
| Q2 2019 | $1,426,000 | +35.4% | 532,031 | +49.6% | 0.01% | +66.7% |
| Q1 2019 | $1,053,000 | -43.5% | 355,737 | -69.6% | 0.00% | -57.1% |
| Q4 2018 | $1,863,000 | +940.8% | 1,171,696 | +2305.8% | 0.01% | – |
| Q3 2018 | $179,000 | -63.9% | 48,703 | -72.2% | 0.00% | -100.0% |
| Q2 2018 | $496,000 | -84.5% | 175,222 | -84.2% | 0.00% | -90.0% |
| Q4 2017 | $3,190,000 | +101.3% | 1,107,595 | +188.7% | 0.01% | +66.7% |
| Q4 2016 | $1,585,000 | +56.0% | 383,676 | +206.0% | 0.01% | +50.0% |
| Q3 2016 | $1,016,000 | +947.4% | 125,387 | +906.9% | 0.00% | – |
| Q2 2016 | $97,000 | -37.0% | 12,453 | -37.4% | 0.00% | -100.0% |
| Q1 2016 | $154,000 | -62.0% | 19,900 | -46.9% | 0.00% | -50.0% |
| Q4 2015 | $405,000 | -92.6% | 37,500 | -93.1% | 0.00% | -91.7% |
| Q3 2014 | $5,456,000 | +696.5% | 546,672 | +504.4% | 0.02% | +700.0% |
| Q2 2014 | $685,000 | – | 90,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|